Healthcare Data for Achieving a More Personalized Treatment of Chronic Kidney Disease

The current concept of healthcare incites a more personalized treatment of diseases. To this aim, biomarkers are needed to improve decision-making facing chronic kidney disease (CKD) patients. Prognostic markers provided by real-world (observational) evidence are proposed in this Special Issue entit...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrera-Gómez, Francisco, Álvarez, F. Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145653/
https://www.ncbi.nlm.nih.gov/pubmed/33946653
http://dx.doi.org/10.3390/biomedicines9050488
_version_ 1783697224879833088
author Herrera-Gómez, Francisco
Álvarez, F. Javier
author_facet Herrera-Gómez, Francisco
Álvarez, F. Javier
author_sort Herrera-Gómez, Francisco
collection PubMed
description The current concept of healthcare incites a more personalized treatment of diseases. To this aim, biomarkers are needed to improve decision-making facing chronic kidney disease (CKD) patients. Prognostic markers provided by real-world (observational) evidence are proposed in this Special Issue entitled “Biomarkers in Chronic Kidney Disease”, with the intention to identify high-risk patients. These markers do not target measurable parameters in patients but clinical endpoints that may be in turn transformed to benefits under the effect of future interventions.
format Online
Article
Text
id pubmed-8145653
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81456532021-05-26 Healthcare Data for Achieving a More Personalized Treatment of Chronic Kidney Disease Herrera-Gómez, Francisco Álvarez, F. Javier Biomedicines Editorial The current concept of healthcare incites a more personalized treatment of diseases. To this aim, biomarkers are needed to improve decision-making facing chronic kidney disease (CKD) patients. Prognostic markers provided by real-world (observational) evidence are proposed in this Special Issue entitled “Biomarkers in Chronic Kidney Disease”, with the intention to identify high-risk patients. These markers do not target measurable parameters in patients but clinical endpoints that may be in turn transformed to benefits under the effect of future interventions. MDPI 2021-04-29 /pmc/articles/PMC8145653/ /pubmed/33946653 http://dx.doi.org/10.3390/biomedicines9050488 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Herrera-Gómez, Francisco
Álvarez, F. Javier
Healthcare Data for Achieving a More Personalized Treatment of Chronic Kidney Disease
title Healthcare Data for Achieving a More Personalized Treatment of Chronic Kidney Disease
title_full Healthcare Data for Achieving a More Personalized Treatment of Chronic Kidney Disease
title_fullStr Healthcare Data for Achieving a More Personalized Treatment of Chronic Kidney Disease
title_full_unstemmed Healthcare Data for Achieving a More Personalized Treatment of Chronic Kidney Disease
title_short Healthcare Data for Achieving a More Personalized Treatment of Chronic Kidney Disease
title_sort healthcare data for achieving a more personalized treatment of chronic kidney disease
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145653/
https://www.ncbi.nlm.nih.gov/pubmed/33946653
http://dx.doi.org/10.3390/biomedicines9050488
work_keys_str_mv AT herreragomezfrancisco healthcaredataforachievingamorepersonalizedtreatmentofchronickidneydisease
AT alvarezfjavier healthcaredataforachievingamorepersonalizedtreatmentofchronickidneydisease

Ejemplares similares